Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of heart failure and/or post infarct pathological remodeling by ex vivo reprogrammed immune cells

Treatment of heart failure and/or post infarct pathological remodeling by ex vivo reprogrammed immune cells

US Patent 12385011 · Granted Aug 12, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of cerebral palsy using fibroblasts2025
Prevention of recurrent miscarriages through administration of fibroblasts and f2025
Prevention and/or treatment of type 1 diabetes by augmentation of myeloid suppre2025
Prevention and/or treatment of type 1 diabetes by augmentation of myeloid suppre2025
Stimulation of angiogenesis by fibroblast derived exosomes2025
Interaction of fibroblasts and immune cells for activation and uses thereof2025
Treatment of opioid addiction using fibroblasts and products thereof2024
Fibroblast therapy for treatment of Duchenne muscular dystrophy2024
Stimulation of mesenchymal stem cell therapeutic activities by T regulatory cell2024
Treatment of chronic obstructive pulmonary disease and lung degeneration using a2024
Augmentation of cell therapy efficacy including treatment with alpha 1,3 fucosyl2024
Prevention of neuroinflammation associated memory loss using nutraceutical compo2024